What are the outcomes of declining a public health service increased risk liver donor for patients on the liver transplant waiting list?
- 17 January 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 24 (4) , 497-504
Abstract
The tragedy of the national opioid epidemic has resulted in a significant increase in the number of opioid‐related deaths and accordingly an increase in the number of potential donors designated Public Health Service (PHS) increased risk. Previous studies have demonstrated reluctance to use these PHS organs, and as a result, higher discard rates for these organs have been observed. All patients listed for liver transplantation in the United States from January 2005 to December 2016 were investigated. Patients on the waiting list were divided into 2 groups: those in which a PHS liver was used for transplantation (accepted PHS group) and those in which a PHS liver was declined and transplanted into a recipient lower on the match run (declined PHS group). Intention‐to‐treat patient survival from the time of PHS offer was significantly higher in the accepted PHS compared with the declined PHS group (P < 0.001). On Cox multivariate regression, declining a PHS donor liver was associated with a hazard ratio of 2.36 (95% confidence interval, 2.23‐2.49; P < 0.001). For patients in which a PHS organ offer was declined, 11.6% died or were delisted for being too sick within the subsequent year. Donor liver allografts implanted in the accepted PHS group were of a lower donor risk index (1.28 versus 1.44) compared with the non‐PHS organs that patients in the declined PHS group ultimately received if they underwent transplantation. In conclusion, there is a significantly higher survival for patients in which a PHS liver is accepted and used compared with those patients in which a PHS organ is declined. These data will help inform decisions about whether or not to accept a PHS donor liver for both patients and transplant professionals. Liver Transplantation 24 497–504 2018 AASLD.Keywords
This publication has 22 references indexed in Scilit:
- Deceased Organ Donors and PHS Risk IdentificationTransplantation, 2017
- The “PHS Increased Risk” Label Is Associated With Nonutilization of Hundreds of Organs per YearTransplantation, 2017
- Noneligible Donors as a Strategy to Decrease the Organ ShortageAmerican Journal of Transplantation, 2017
- Improving Organ Utilization to Help Overcome the Tragedies of the Opioid EpidemicAmerican Journal of Transplantation, 2016
- The impact of broader regional sharing of livers: 2‐year results of “Share 35”Liver Transplantation, 2016
- Donor-Derived Transmission Events in 2013Transplantation, 2015
- Recurrent HCV after liver transplantation—mechanisms, assessment and therapyNature Reviews Gastroenterology & Hepatology, 2014
- An Examination of Liver Offers to Candidates on the Liver Transplant Wait-ListGastroenterology, 2012
- Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma#*Liver Transplantation, 2012
- Model for end-stage liver disease (MELD) and allocation of donor liversGastroenterology, 2003